Compare SpaceX (SPCX) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SpaceX vs Tenet Healthcare Corporation — how do they compare? SpaceX trades at $124.29 (market cap $1.58T), while Tenet Healthcare Corporation trades at $196.03 (market cap $16.74B). The key difference: SpaceX is far larger — about 94.4× Tenet Healthcare Corporation's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, SpaceX nearer its low. Which is the better fit depends on your goals.
| SPCX | THC | |
|---|---|---|
Market Cap | $1.58T | $16.74B |
Sector | Technology | Health |
52-Week High | $202.09 | $244.80 |
52-Week Low | $119.85 | $148.38 |
Enterprise Value | $1.59T | $26.99B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SPCX trades at $119.85, down 3.34% over 24 hours amid volatile post-IPO performance. The stock shows mixed technical signals with bearish moving averages but bullish oscillators. Fundamentally, the company reported a net loss of $4.94B on $18.67B revenue in 2025, with negative margins and elevated valuation ratios. Recent news highlights upcoming earnings on August 4, 2026, and a significant share unlock event, contributing to heightened investor attention and short interest.
Despite current losses, analyst consensus remains strongly bullish with a $237.78 price target, citing long-term AI infrastructure potential. Key risks include high short interest, lock-up expirations, and execution challenges in scaling profitability. The stock presents a high-risk, high-reward opportunity dependent on future earnings improvements and market sentiment shifts.
Tenet Healthcare (THC) trades at $194.38, down 0.27% on the day, with a bearish technical signal but strong fundamentals. The stock has beaten EPS estimates for three consecutive quarters, with a Q2 2026 report due July 24. Valuation metrics appear attractive with a P/E of 10.11 and P/S of 0.79. Revenue and net income are projected to grow in 2026, supported by expansion in outpatient care.
The outlook is positive given analyst consensus with 81% buy ratings and a $234.63 price target, implying 21% upside. Risks include potential pressure from lower patient days and high debt levels. Earnings growth and ambulatory care performance remain key catalysts for near-term momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SpaceX
SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.
Read more on SPCX →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
